C - Chemistry – Metallurgy – 07 – H
Patent
C - Chemistry, Metallurgy
07
H
C07H 21/00 (2006.01) A61K 31/70 (2006.01) C12N 15/11 (2006.01)
Patent
CA 2152903
The present invention is directed to a polynucleotide of about 10 to about 50 nucleic acid bases in length, which polynucleotide hybridizes to the gene encoding fibroblast growth factor receptor. The present invention is also directed to a pharmaceutical composition comprising the above polynucleotide dissolved or dispersed in a physiologically tolerable diluent. The present invention is further directed to a process for inhibiting vascular smooth muscle cell proliferation (figs. 1 and 2), a process for treating vascular smooth muscle cell proliferation (figs. 3 and 4), and a process for treating a disease state involving vascular smooth muscle cell proliferation (figs. 3 and 4), all of which processes comprise contacting vascular smooth muscle cells or administering an effective amount of a polynucleotide of about 10 to about 50 nucleic acid bases in length, said polynucleotide hybridizing to the gene for fibroblast growth factor receptor. I
Denner Larry A.
Dixon Richard A. F.
Rege Ajay A.
Denner Larry A.
Dixon Richard A. F.
Rege Ajay A.
Swabey Ogilvy Renault
Texas Biotechnology Corporation
LandOfFree
Antisense molecules directed against a fibroblast growth... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense molecules directed against a fibroblast growth..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense molecules directed against a fibroblast growth... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1486954